Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate neurological findings with TSPO-PET and MRI in patients who have been exposed to indoor air pollutants and have potentially neurological symptoms.
Health problems related to indoor air pollutants have been studied for several decades but there is still not sufficient scientific evidence to prove the association between many of the described symptoms and exposure to mold and other air pollutants.
This research aims on studying the activation of microglia and inflammation in the brains of individuals exposed to indoor air pollutants having neurological symptoms with MRI and TSPO-PET imaging, questionnaires and biomarkers and compare the findings to individuals having neurological conditions without exposure to indoor air pollutants as well as healthy controls.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Indoor air pollutant groups | 50 patients that have been exposed to indoor air pollutants | ||
| Neurological symptoms groups | 50 patients with neurological symptoms possibly due to adverse external exposure without any exposure to indoor air pollutants | ||
| Healthy controls | 25 healthy age- and gender-matched controls |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| [11C]PK11195 binding in the brain | Change in microglial activity in the brains of the individuals in different study groups as measured by [11C]PK11195 PET imaging | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| DTI-MRI metrics | To evaluate the microstructural damage of the brain between individuals in different groups | Baseline |
| Results from questionnaires | Questionnaires about quality of life compared between the indoor air pollutant and neurological symptoms groups |
Not provided
Inclusion Criteria:
All:
Indoor air pollutant groups:
Neurological symptoms groups:
Healthy controls:
Exclusion Criteria:
All:
Neurological symptoms groups and healthy controls:
Not provided
Not provided
Not provided
The study will recruit 50 patients who have been exposed to indoor air pollutants and have possibly neurological symptoms. For comparison the study will recruit also 50 patients with neurological symptoms due to a possible adverse external exposure and who have not been exposed to indoor air pollutants. Additionally, 25 healthy controls will be included.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Laura Airas, MD,Professor | Turku University Hospital, division of clinical neurosciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Turku PET Centre | Turku | Southwest Finland | 20520 | Finland |
Not provided
Not provided
Not provided
Not provided
Blood and cerebrospinal fluid
| Baseline |
| Blood biomarkers | Biomarkers measured from blood to assess the possible inflammatory state of individuals in different study groups | Baseline |
| Neurography measures | Done additionally if clinical studies indicate necessary, to assess the state of peripheral nerves | Baseline |
| Electromyography measures | Done additionally if clinical studies indicate necessary, rating each examined muscle as normal/myopathic/neuropathic | Baseline |
| Cerebrospinal fluid biomarkers | Biomarkers measured from cerebrospinal fluid to assess the possible inflammatory state of individuals in different study groups | Baseline |